Clinical Trials Directory

Trials / Completed

CompletedNCT04939753

Nephrogenic Diabetes Insipidus During Prolonged Sevoflurane Sedation in the ICU: a Retrospective Analysis

Incidence of Nephrogenic Diabetes Insipidus During Prolonged Sevoflurane Sedation in the Intensive Care Unit: a Retrospective Analysis

Status
Completed
Phase
Study type
Observational
Enrollment
1,000 (actual)
Sponsor
Universitair Ziekenhuis Brussel · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

The investigators aim to retrospectively explore the electronic medical records of all patients who were admitted to the Intensive Care Unit (ICU) of the UZ Brussels in the last 10 years (March 1st 2011- March 1st 2021) and who received prolonged sedation (\>24h) with sevoflurane.

Conditions

Interventions

TypeNameDescription
DRUGSevofluraneSevoflurane administration to sedate the patient

Timeline

Start date
2021-05-26
Primary completion
2023-04-01
Completion
2023-04-01
First posted
2021-06-25
Last updated
2023-04-27

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT04939753. Inclusion in this directory is not an endorsement.